Ranbaxy Laboratories Ltd. - Research Center
500359 RANBAXY Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 14 | Dec ' 12 | Dec ' 11 | Dec ' 10 | Dec ' 09 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 211.66 | 211.46 | 211.00 | 210.52 | 210.21 |
| Share application money | 0.50 | 1.11 | 0.67 | 6.60 | 175.85 |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 884.83 | 1,709.51 | 1,713.16 | 4,915.28 | 3,748.54 |
| Loan funds | |||||
| Secured loans | 1,011.75 | 944.18 | 229.59 | 195.39 | 175.83 |
| Unsecured loans | 4,979.31 | 3,819.43 | 3,653.82 | 4,065.33 | 3,172.55 |
| Total | 7,088.06 | 6,685.68 | 5,808.24 | 9,393.11 | 7,482.99 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 3,337.81 | 3,118.22 | 2,886.15 | 2,857.63 | 2,620.92 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 1,325.67 | 1,124.69 | 1,019.15 | 1,145.52 | 1,027.52 |
| Net block | 2,012.13 | 1,993.53 | 1,867.00 | 1,712.12 | 1,593.41 |
| Capital work-in-progress | 183.63 | 159.60 | 209.12 | 330.18 | 414.92 |
| Investments | 4,080.88 | 3,131.17 | 3,410.79 | 3,804.44 | 3,833.69 |
| Net current assets | |||||
| Current assets, loans & advances | 6,828.39 | 7,685.64 | 8,834.01 | 6,965.27 | 5,486.90 |
| Less : current liabilities & provisions | 6,016.98 | 6,284.25 | 8,512.68 | 3,418.90 | 3,845.92 |
| Total net current assets | 811.40 | 1,401.39 | 321.33 | 3,546.37 | 1,640.97 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 7,088.06 | 6,685.68 | 5,808.24 | 9,393.11 | 7,482.99 |
| Notes: | |||||
| Book value of unquoted investments | 4,048.35 | 3,027.17 | 3,306.19 | 3,698.52 | 3,569.70 |
| Market value of quoted investments | 28.51 | 50.43 | 63.61 | 92.67 | 380.72 |
| Contingent liabilities | 1,222.20 | 789.63 | 927.85 | 276.13 | 261.05 |
| Number of equity sharesoutstanding (Lacs) | 4237.79 | 4229.14 | 4220.00 | 4210.41 | 4204.17 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis